Short Interest in abrdn Life Sciences Investors (NYSE:HQL) Grows By 339.8%

abrdn Life Sciences Investors (NYSE:HQL) was the recipient of a significant increase in short interest during the month of July. As of July 15th, there was short interest totaling 62,733 shares, an increase of 339.8% from the June 30th total of 14,265 shares. Based on an average daily trading volume, of 144,503 shares, the days-to-cover ratio is currently 0.4 days. Currently, 0.2% of the shares of the company are short sold.

Institutional Investors Weigh In On abrdn Life Sciences Investors

Hedge funds have recently modified their holdings of the stock. Allspring Global Investments Holdings LLC grew its position in abrdn Life Sciences Investors by 57.3% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 362,535 shares of the company’s stock valued at $5,898,000 after buying an additional 132,098 shares during the last quarter. LPL Financial LLC raised its position in abrdn Life Sciences Investors by 20.0% during the 4th quarter. LPL Financial LLC now owns 448,846 shares of the company’s stock worth $7,532,000 after buying an additional 74,787 shares during the last quarter. Landscape Capital Management L.L.C. purchased a new position in abrdn Life Sciences Investors during the 4th quarter worth $1,158,000. Raymond James Financial Inc. raised its position in abrdn Life Sciences Investors by 20.3% during the 2nd quarter. Raymond James Financial Inc. now owns 375,960 shares of the company’s stock worth $4,816,000 after buying an additional 63,429 shares during the last quarter. Finally, Formidable Asset Management LLC lifted its stake in shares of abrdn Life Sciences Investors by 63.3% in the 4th quarter. Formidable Asset Management LLC now owns 124,445 shares of the company’s stock worth $1,930,000 after acquiring an additional 48,252 shares during the period. 32.21% of the stock is owned by institutional investors and hedge funds.

abrdn Life Sciences Investors Stock Down 2.0%

HQL opened at $19.23 on Friday. abrdn Life Sciences Investors has a 52 week low of $13.01 and a 52 week high of $21.32. The business has a 50 day moving average price of $18.53 and a two-hundred day moving average price of $17.54.

abrdn Life Sciences Investors Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Thursday, May 21st were issued a $0.56 dividend. The ex-dividend date of this dividend was Thursday, May 21st. This represents a $2.24 dividend on an annualized basis and a dividend yield of 11.6%.

About abrdn Life Sciences Investors

abrdn Life Sciences Investors (NYSE: HQL) is a closed-end management investment company that seeks capital appreciation through investment in the life sciences sector. Established in 1994, the trust focuses on equity and equity-related securities of companies engaged in biotechnology, pharmaceuticals, medical devices, diagnostics and related fields. Its closed-end structure allows portfolio managers to maintain a stable pool of capital, pursue long-term investment strategies and employ leverage when deemed appropriate.

The fund’s portfolio spans both public and private companies, with an emphasis on businesses driving innovation in drug development, gene therapy, precision medicine and healthcare technology.